Form 4 Tracker
Mark Mossler

Chief Accounting Officer · 1 filing · Latest: Feb 13, 2026

C4 Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
CCCC
Mark MosslerMay 27, 2026
Proposed Sale
$3.919,087$35.5K
CCCC
Mark MosslerChief Accounting OfficerFeb 14, 2026
Option Exercise
$0.009,42075,184